Ruchi Gupta

Ruchi Gupta

Company: Johnson & Johnson

Job title: Director

Seminars:

Chair’s Opening Remarks 8:50 am

Read more

day: Day Two

Panel Discussion: Defining the Therapeutic Windows of Drugs to Ensure Patient Safety Whilst Maintaining Drug Efficacy 9:50 am

Balancing the therapeutic index versus safety in targeting complement Discussing this in the context of disease versus healthy complement inhibition Reviewing the therapeutic window when you target classical, lectin or alternative pathways Discussing pharmacokinetics of targeting complement Specifying inclusion/exclusion criteria put in place specifically due to safety considerations e.g. avoiding comorbidities or infectionsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.